China AI: Deep questions
Concerns around valuations, commercialization timelines, deal targeting, and brand perceptions are coming into focus as China’s AI ecosystem catapults to global prominence
In the course of a decade, China has become a global leader in artificial intelligence (AI) due to a combination of strengths in data collection and processing capacity, as well as a focused political...
More on Greater China
Latest News
Chinese O2O language training provider files for US IPO
Meten International Education Group, a Chinese online-to-offline (O2O) English language training provider that mainly caters to adult students, has filed for a US IPO. DG Capital is the primary PE investor in the company.
Singapore's VisVires launches $150m food tech fund
VisVires New Protein, a Singapore-based VC firm specializing in food technology, has launched its second fund with a target of $150 million. Fund I closed at $40 million in 2016.
China’s Allist Pharmaceuticals raises $171m Series A
Shanghai-based drug developer Allist Pharmaceuticals has raised RMB1.2 billion ($171 million) in a Series A round of funding led by Shiyu Capital. Other participants include Loyal Valley Capital and Suzhou Industrial Park Bioventure Investment.
SBI joins $35m Series B for Japan's Pixie Dust
SBI Investment, the VC arm of Japan’s SBI Holdings, has joined a JPY3.8 billion $35 million Series B round for Pixie Dust Technologies, a local company developing novel uses for ultrasonic waves.